• Perospirone Inhibits Vascular Kv1.5 Channels: Cardiovascular

  2026-05-20

  A recent study demonstrates that Perospirone (SM-9018 free base), an atypical antipsychotic, directly inhibits voltage-gated Kv1.5 potassium channels in coronary arterial smooth muscle cells. This off-target effect has significant implications for understanding both cardiovascular safety and the translational modeling of neuropsychiatric disorders.

• Biotin-XX Tyramide Reagent: Redefining Cell Surface Signal A

  2026-05-20

  Explore how Biotin-XX Tyramide Reagent transforms membrane-impermeant proximity labeling for advanced stem cell migration research. This article delves into its unique advantages for high-sensitivity immunohistochemistry and in situ hybridization, highlighting recent breakthroughs.

• 5-(N,N-dimethyl)-Amiloride Hydrochloride for Endothelial Inj

  2026-05-19

  5-(N,N-dimethyl)-Amiloride hydrochloride (DMA) stands out as a selective Na+/H+ exchanger inhibitor, enabling precise dissection of intracellular pH regulation and endothelial dysfunction, especially in sepsis and cardiovascular models. Learn how APExBIO’s DMA empowers robust workflows, troubleshooting, and breakthrough biomarker-driven studies.

• CD44-Driven Metabolic Rewiring in IDH-Mutant AML: Therapeuti

  2026-05-19

  This study uncovers CD44 as an essential mediator of metabolic rewiring in IDH-mutant acute myeloid leukemia, enabling sustained oncometabolite (R)-2-hydroxyglutarate production. By mechanistically linking CD44 activation to pentose phosphate pathway flux and therapy resistance, the findings suggest new combinatorial vulnerabilities for targeted intervention.

• Talabostat Mesylate (PT-100): Advanced Workflows for Tumor M

  2026-05-18

  Talabostat mesylate (PT-100) is revolutionizing tumor microenvironment research by precisely inhibiting DPP4 and FAP, enabling selective modulation of cytokine production and immune responses. This guide delivers actionable workflows, protocol refinements, and troubleshooting insights to maximize research impact with APExBIO’s trusted compound.

• Shufeng Xingbi Therapy Modulates Immunity and Microbiota in

  2026-05-18

  This study demonstrates that Shufeng Xingbi Therapy (SFXBT) restores Th1/Th2 immune balance and remodels intestinal flora in a rat model of allergic rhinitis (AR). The work provides mechanistic insight into how traditional herbal interventions impact immune signaling and gut-lung axis, with relevance for future translational and mechanistic research.

• Rosemary Extract Disrupts Amyloid Formation in Renal Amyloid

  2026-05-17

  This multidimensional study demonstrates that rosemary ethanol extract (REE) disrupts amyloid fibril formation, restores subcellular homeostasis, and attenuates apoptosis in renal amyloidosis models. The findings provide mechanistic insight into potential adjuvant therapies for kidney amyloid diseases and inform apoptosis assay design.

• AG-120 (Ivosidenib): Optimizing IDH1-Mutant AML Workflows

  2026-05-16

  AG-120 (Ivosidenib) transforms mutant IDH1 research with precise 2-hydroxyglutarate reduction and robust myeloid differentiation induction. This guide details evidence-backed protocols, troubleshooting, and advanced applications, empowering labs to maximize experimental power and reproducibility.

• Gamma-linolenic Acid (GLA): Translational Insights in Anti-I

  2026-05-15

  Explore the molecular pharmacology of gamma-linolenic acid (GLA) with an emphasis on its anti-inflammatory mechanisms and research applications. This cornerstone article uniquely analyzes GLA's translational relevance for assay design and clinical modeling.

• Angiotensin II (SKU A1042): Reliable Workflows for Vascular

  2026-05-15

  This scenario-driven article addresses the real-world challenges of using Angiotensin II in cell viability, proliferation, and cytotoxicity assays. Drawing on validated protocols and recent literature, it demonstrates how SKU A1042 from APExBIO offers reproducible, quantitative, and cost-effective solutions for vascular smooth muscle cell hypertrophy research, hypertension mechanism studies, and abdominal aortic aneurysm models.

• p53 Modulates ERCC1-Deficient Lung Cancer Response to Cispla

  2026-05-14

  This study uncovers how p53 status critically determines the survival of ERCC1-deficient lung cancer cells following cisplatin-induced DNA damage. The findings explain why ERCC1 expression alone is insufficient as a predictive biomarker for platinum chemotherapy, highlighting the importance of integrating p53 status in biomarker strategies.

• URB597 (KDS-4103): Optimizing Endocannabinoid Assays in the

  2026-05-14

  This article provides a scenario-driven, evidence-based guide for life science researchers applying URB597 (SKU A4372) in cell viability, neuroplasticity, and neuroinflammation workflows. It addresses common pitfalls in FAAH inhibition and endocannabinoid signaling studies, illustrating how URB597 offers reproducibility and sensitivity. Practical recommendations and protocol parameters are included to ensure rigorous and reliable experimentation.

• Cefotaxime in Antimicrobial Resistance Research Workflows

  2026-05-13

  Cefotaxime, a third-generation cephalosporin antibiotic, is pivotal for dissecting resistance mechanisms in both Gram-positive and Gram-negative bacteria. This guide details experimental setup, workflow optimization, and troubleshooting for robust and reproducible antimicrobial resistance research using APExBIO's high-purity Cefotaxime.

• Intravitreal Metformin Suppresses CNV and Retinal Degenerati

  2026-05-13

  This study demonstrates that intravitreal metformin effectively reduces choroidal neovascularization and protects against light-induced retinal degeneration in mouse models of age-related macular degeneration. By elucidating metformin's anti-angiogenic and neuroprotective mechanisms, the research highlights its potential as a cost-effective adjunct to current therapies.

• Viral Induced RIPK3 Degradation Modulates Necroptosis and In

  2026-05-12

  This study identifies a class of orthopoxvirus proteins, termed vIRD, that induce ubiquitin-mediated proteasomal degradation of RIPK3, thereby suppressing necroptosis and regulating virus-induced inflammation. The findings reveal a sophisticated viral strategy to modulate host cell death pathways and highlight the role of ubiquitin-proteasome system manipulation in pathogen-host interactions.

15495 records 1/1033 page Next 12345 下5页 Last page